1 |
Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U, et al. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J Clin Invest 1997;100:1047-58.
DOI
ScienceOn
|
2 |
Moon JY, Jeong L, Lee S, Jeong K, Lee T, Ihm CG, et al. Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus J Korean Med Sci 2007;22:810-4.
DOI
ScienceOn
|
3 |
Mori H, Kaneko Y, Narita I, Goto S, Saito N, Kondo D, et al. Monocyte chemoattractant protein-1 A-2518G gene polymorphism and renal survival of Japanese patients with immunoglobulin A nephropathy. Clin Exp Nephrol 2005;9:297-303.
DOI
ScienceOn
|
4 |
Ye DQ, Yang SG, Li XP, Hu YS, Yin J, Zhang GQ, et al. Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosus. Arch Dermatol Res 2005;297:108-13.
DOI
ScienceOn
|
5 |
Kim HL, Lee DS, Yang SH, Lim CS, Chung JH, Kim S, et al. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 2002;40:1146-52.
DOI
ScienceOn
|
6 |
Maruyama K, Yoshida M, Nishio H, Shirakawa T, Kawamura T, Tanaka R, et al. Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 2001;16:350-5.
DOI
ScienceOn
|
7 |
Brabcova I, Petrasek J, Hribova P, Hyklova K, Bartosova K, Lacha J, et al. Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation. Transplantation 2007;84: 1037-44.
DOI
ScienceOn
|
8 |
Nakanishi K, Sako M, Yata N, Aoyagi N, Nozu K, Tanaka R, et al. A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy. Pediatr Nephrol 2004;19:144-7.
DOI
ScienceOn
|
9 |
Mlynarski WM, Placha GP, Wolkow PP, Bochenski JP, Warram JH, Krolewski AS. Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sexspecific effect. Diabetes 2005;54:3331-5.
DOI
ScienceOn
|
10 |
Malafronte P, Vieira JM, Jr., Pereira AC, Krieger JE, Barros RT, Woronik V. Association of the MCP-1 -2518 A/G Polymorphism and No Association of Its Receptor CCR2 -64 V/I Polymorphism with Lupus Nephritis. J Rheumatol 2010;37:776-8.
DOI
ScienceOn
|
11 |
Nakashima H, Akahoshi M, Shimizu S, Inoue Y, Miyake K, Ninomiya I, et al. Absence of association between the MCP-1 gene polymorphism and histological phenotype of lupus nephritis. Lupus 2004;13:165-7.
DOI
ScienceOn
|
12 |
Das L, Brunner HI. Biomarkers for renal disease in childhood. Curr Rheumatol Rep 2009;11:218-25.
DOI
ScienceOn
|
13 |
Steinmetz OM, Panzer U, Harendza S, Mertens PR, Ostendorf T, Floege J, et al. No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy. Nephrol Dial Transplant 2004;19:596-601.
DOI
|
14 |
Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, et al. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system. Nephrol Dial Transplant 2005;20: 342-8.
DOI
|
15 |
Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006;22: 1928-9.
DOI
ScienceOn
|
16 |
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
DOI
ScienceOn
|
17 |
Dantas M, Romao EA, Costa RS, dos Reis MA, Vieira Neto OM, Ribeiro RA, et al. Urinary excretion of monocyte chemoattractant protein-1: a biomarker of active tubulointerstitial damage in patients with glomerulopathies. Kidney Blood Press Res 2007;30:306-13.
DOI
ScienceOn
|
18 |
Tucci M, Barnes EV, Sobel ES, Croker BP, Segal MS, Reeves WH, et al. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum 2004;50:1842-9.
DOI
ScienceOn
|
19 |
Tesch GH. MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 2008;294:F697-701.
DOI
ScienceOn
|
20 |
Yao TC, Kuo ML, See LC, Ou LS, Lee WI, Chan CK, et al. RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study. Arthritis Rheum 2006; 54:2585-93.
DOI
ScienceOn
|
21 |
Mokubo A, Tanaka Y, Nakajima K, Watada H, Hirose T, Kawasumi M, et al. Chemotactic cytokine receptor 5 (CCR5) gene promoter polymorphism (59029A/G) is associated with diabetic nephropathy in Japanese patients with type 2 diabetes: a 10-year longitudinal study. Diabetes Res Clin Pract 2006;73:89-94.
DOI
ScienceOn
|
22 |
Nakajima K, Tanaka Y, Nomiyama T, Ogihara T, Ikeda F, Kanno R, et al. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care 2003;26:892-8.
DOI
ScienceOn
|
23 |
Song E, Zou H, Yao Y, Proudfoot A, Antus B, Liu S, et al. Early application of Met- RANTES ameliorates chronic allograft nephropathy. Kidney Int 2002;61:676-85.
DOI
ScienceOn
|
24 |
Joo KW, Hwang YH, Kim JH, Oh KH, Kim H, Shin HD, et al. MCP-1 and RANTES polymorphisms in Korean diabetic endstage renal disease. J Korean Med Sci 2007;22:611-5.
DOI
ScienceOn
|
25 |
Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, Gupta R, et al. Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet 2007;8:20.
|
26 |
Brown KS, Nackos E, Morthala S, Jensen LE, Whitehead AS, Von Feldt JM. Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus. J Rheumatol 2007;34:740-6.
|
27 |
Ahluwalia TS, Khullar M, Ahuja M, Kohli HS, Bhansali A, Mohan V, et al. Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians. PLoS One 2009;4:e5168.
DOI
|
28 |
Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez-Roldan A. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 2001;58:335-8.
DOI
ScienceOn
|
29 |
Tian S, Li J, Wang L, Liu T, Liu H, Cheng G, et al. Urinary levels of RANTES and MCSF are predictors of lupus nephritis flare. Inflamm Res 2007;56:304-10.
DOI
ScienceOn
|
30 |
Furuichi K, Wada T, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, et al. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Am J Nephrol 2000;20:291-9.
DOI
ScienceOn
|
31 |
Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Li PK, et al. Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis. Nephrology (Carlton) 2006;11:219-25.
DOI
ScienceOn
|
32 |
Vielhauer V, Berning E, Eis V, Kretzler M, Segerer S, Strutz F, et al. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int 2004;66:2264-78.
DOI
ScienceOn
|
33 |
Wada T, Yokoyama H, Furuichi K, Kobayashi KI, Harada K, Naruto M, et al. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J 1996;10:1418-25.
DOI
|
34 |
Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TN, Salant DJ, et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997;185: 1371-80.
DOI
ScienceOn
|
35 |
Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, et al. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein- 1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology (Carlton) 2009; 14:613-20.
DOI
ScienceOn
|
36 |
Wagrowska-Danilewicz M, Danilewicz M, Stasikowska O. CC chemokines and chemokine receptors in IgA nephropathy (IgAN) and in non-IgA mesangial proliferative glomerulonephritis (MesProGN). the immunohistochemical comparative study. Pol J Pathol 2005;56:121-6.
|
37 |
Cheng J, Diaz Encarnacion MM, Warner GM, Gray CE, Nath KA, Grande JP. TGF-beta1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process. Am J Physiol Cell Physiol 2005;289:C959-70.
DOI
|
38 |
Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000;58:1492-9.
DOI
ScienceOn
|